Exact Sciences Corporation logo
Exact Sciences Corporation EXAS

Annual report 2025
added 02-13-2026

report update icon

Exact Sciences Corporation Interest Expense 2011-2026 | EXAS

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.
Includes:
  • Interest on bank loans
  • Interest on corporate bonds
  • Interest on leases
  • Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Exact Sciences Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 18.6 M 67.9 M 199 M 36.8 M 206 K -213 K 6 K 51 K 69 K 41 K 21 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
199 M -213 K 29.3 M

Quarterly Interest Expense Exact Sciences Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - -9.61 M 111 K -7.94 M - -7.87 M -7.82 M 4.11 M - -5.24 M -4.51 M -4.48 M - -4.68 M -4.65 M -4.62 M - 23.6 M 22.9 M 25.2 M -13.7 M 13.2 M 12.7 M 22 M -11 M 10.7 M 8.6 M -6.51 M -51 K -51 K -54 K -50 K -52 K -54 K -53 K 54 K -62 K -40 K 107 K 11 K 11 K 12 K 13 K 15 K 16 K 16 K 18 K 19 K 20 K 11 K 5 K 5 K 6 K 5 K 5 K 5 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
25.2 M -13.7 M 988 K

Interest Expense of other stocks in the Diagnostics research industry

Issuer Interest Expense Price % 24h Market Cap Country
Enzo Biochem Enzo Biochem
ENZ
494 K - -8.98 % $ 14.8 K usaUSA
Centogene N.V. Centogene N.V.
CNTG
8.42 M - -6.23 % $ 30.6 M germanyGermany
Heska Corporation Heska Corporation
HSKA
4.19 M - - $ 1.31 B usaUSA
DermTech DermTech
DMTK
-355 K - -11.32 % $ 2.94 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
26 M $ 201.41 -0.81 % $ 22.4 B usaUSA
Celcuity Celcuity
CELC
5.33 M $ 87.87 -0.77 % $ 4.11 B usaUSA
Akumin Akumin
AKU
118 M - -17.87 % $ 25.9 M canadaCanada
Co-Diagnostics Co-Diagnostics
CODX
106 K $ 4.05 -5.71 % $ 5.39 M usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
153 K $ 18.82 0.74 % $ 579 M usaUSA
Castle Biosciences Castle Biosciences
CSTL
144 K $ 20.98 1.35 % $ 608 M usaUSA
Aspira Women's Health Aspira Women's Health
AWH
1.81 M - -6.19 % $ 10.5 M usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
-595 K - -61.36 % $ 2.46 M usaUSA
Biocept Biocept
BIOC
316 K - -13.05 % $ 7.29 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
-394 K $ 1.64 2.19 % $ 7.26 M usaUSA
Guardant Health Guardant Health
GH
-10.5 M $ 132.35 0.55 % $ 16.6 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
524 K $ 23.83 3.74 % $ 1.27 B usaUSA
Illumina Illumina
ILMN
340 M $ 166.13 3.21 % $ 25.8 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
2.94 K - 0.22 % $ 16.8 M usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
13 K - - $ 9.42 M israelIsrael
ICON Public Limited Company ICON Public Limited Company
ICLR
337 M $ 147.98 1.23 % $ 11.6 B irlandaIrlanda
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
857 K - -20.0 % $ 1.06 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
6.27 M - - $ 399 M chinaChina
Mettler-Toledo International Mettler-Toledo International
MTD
68.5 M $ 1 161.11 2.62 % $ 23.9 B schweizSchweiz
Genetic Technologies Limited Genetic Technologies Limited
GENE
17.6 K - - $ 7.1 B australiaAustralia
NeoGenomics NeoGenomics
NEO
296 K $ 11.21 0.54 % $ 1.44 B usaUSA
National Research Corporation National Research Corporation
NRC
-95 K $ 18.77 -0.11 % $ 420 M usaUSA
Natera Natera
NTRA
4.07 M $ 216.16 1.93 % $ 29.6 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
31.3 M $ 104.54 0.02 % $ 7.06 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
-22.6 M $ 190.24 1.46 % $ 9.43 B usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
14.8 M $ 1.39 5.81 % $ 417 M usaUSA
Medpace Holdings Medpace Holdings
MEDP
-5.34 M $ 468.22 0.19 % $ 13.5 B usaUSA
Myriad Genetics Myriad Genetics
MYGN
800 K $ 4.32 -0.23 % $ 400 M usaUSA
Personalis Personalis
PSNL
205 K $ 10.25 6.88 % $ 915 M usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
288 M $ 26.74 1.06 % $ 25.4 B niderlandNiderland
Senseonics Holdings Senseonics Holdings
SENS
-23 K $ 7.31 1.74 % $ 305 M usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
-6.65 M - - $ 10.6 B niderlandNiderland
Soleno Therapeutics Soleno Therapeutics
SLNO
2.58 M - - $ 2.69 B usaUSA
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
-903 K $ 81.92 7.55 % $ 4.9 B usaUSA
Biomerica Biomerica
BMRA
367 $ 2.01 -1.95 % $ 4.62 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
224 M $ 264.57 -0.6 % $ 22 B usaUSA
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
-12 M $ 474.8 1.26 % $ 179 B usaUSA
Trinity Biotech plc Trinity Biotech plc
TRIB
6.75 M $ 0.67 2.52 % $ 241 M irlandaIrlanda
Motus GI Holdings Motus GI Holdings
MOTS
211 - -34.28 % $ 263 K israelIsrael
Neogen Corporation Neogen Corporation
NEOG
38.1 M $ 9.22 1.26 % $ 2 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
56.7 M - - $ 21.2 M usaUSA